We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

Continuing Strong Growth for Viscotek in Europe

Listen with
Speechify
0:00
Register for free to listen to this article
Thank you. Listen to this article using the player above.

Want to listen to this article for FREE?

Complete the form below to unlock access to ALL audio articles.

Read time: Less than a minute

Viscotek has announced strong growth in European sales in 2006 compared to the same period last year. 

The growth has been driven by strong uptake of Viscotek's Model 802 DLS instrument (launched in 2005) and continued investment in the company's Triple Detector Array (TDA) and GPCmax systems by the pharmaceutical industry in particular. 

Manufactured in Europe - Viscotek's Model 802 DLS instrument has been acclaimed by laboratories around the world particularly those specialising in biomolecular discovery, development and delivery, protein-protein interactions, protein conformation analysis and measurement of nanoparticles.

Paul Clarke (MD, Viscotek Europe) stated, "Laboratories evaluating instruments to characterise polymers, proteins and nanoparticulate materials are becoming increasingly aware that not all systems provide the results they are looking for." 

He added, "Continuous investment in innovative new products, experienced and knowledgeable staff and applications development laboratories around Europe has brought its rewards."